Results 1 to 10 of about 53,966 (218)

Intravitreal Bevacizumab plus Methotrexate for iris and ciliary body metastasis from lung cancer [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports
Purpose: To describe a case of iris and ciliary body metastasis from lung adenocarcinoma responding to intravitreal bevacizumab and methotrexate. Observations: A 66-year-old man presented with an amelanotic vascular lesion of the iris and ciliary body (7 
Thaís Marino de Azeredo Bastos   +6 more
doaj   +2 more sources

Effect of intravitreal bevacizumab on kidney function and proteinuria among diabetic patients: a prospective observational study in Asian population [PDF]

open access: yesRenal Failure
Many studies have investigated the ocular benefits of intravitreal bevacizumab but there is scarcity of literature evaluating the effects of bevacizumab on kidney function and proteinuria especially in the Asian population. This study aims to investigate
Brajesh Mourya   +8 more
doaj   +2 more sources

Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy

open access: yesCase Reports in Ophthalmological Medicine, 2015
Purpose. To evaluate the efficacy of intravitreal bevacizumab and triamcinolone in the treatment of cystoid macular oedema in a case with chronic myeloid leukaemia on imatinib treatment. Methods.
Eric K. Newcott   +3 more
doaj   +2 more sources

Use of Intravitreal Bevacizumab Injection among Patients Undergoing Surgical Retinal Interventions at Tertiary Eye Hospital: A Descriptive Cross-sectional Study

open access: yesJournal of Nepal Medical Association, 2021
Introduction: Intravitreal Bevacizumab injection has now become a routine procedure for retina specialists throughout the world. Easy availability of this monoclonal antibody molecule even in Nepal has brought a revolution in the management of various ...
Arjun Shrestha   +4 more
doaj   +1 more source

CENTRAL MACULAR THICKNESS AFTER COMBINED THERAPY OF BEVACIZUMAB INTRAVITREAL INJECTION AND TOPICAL DICLOFENAC COMPARED WITH BEVACIZUMAB INTRAVITREAL INJECTION ALONE IN DIABETIC MACULAR EDEMA

open access: yesIJRETINA (International Journal of Retina), 2021
Introduction: To evaluate whether the combination of diclofenac eye drops and bevacizumab intravitreal injection would provide additional benefits over bevacizumab alone in the treatment of naïve diabetic macular edema (DME).
Melvina Nidya Sandra   +6 more
doaj   +1 more source

Risk factors for an atherothrombotic event in patients with diabetic macular edema treated with intravitreal injections of bevacizumab [PDF]

open access: yesInternational Journal of Ophthalmology, 2020
AIM: To identify risk factors for an atherothrombotic event (ATE) among patients who were treated for diabetic macular edema (DME) with intravitreal bevacizumab injections. METHODS: This retrospective study enrolled all consecutive patients with DME who
Alon Tiosano   +2 more
doaj   +1 more source

Pharmacokinetics and distributions of bevacizumab by intravitreal injection of bevacizumab-PLGA microspheres in rabbits [PDF]

open access: yesInternational Journal of Ophthalmology, 2015
AIM:To investigate the pharmacokinetics and distributions of bevacizumab by intravitreal injection of prepared bevacizumab-poly (L-lactic-co-glycolic acid) (PLGA) microspheres in rabbits, to provide evidence for clinical application of this kind of ...
Zhuo Ye   +5 more
doaj   +1 more source

Indications of Intravitreal Injection of Bevacizumab in a sample of Iraqi patients

open access: yesمجله كليه طب الكندي, 2019
Background: Anti-vascular endothelial growth factors commonly used intravitreally for treatment of variable retinal disease worldwide, which help to regulate the upregulation of vascular endothelial growth factors due to ischemia or/and other retinal ...
Zaid R. Hussein
doaj   +1 more source

Managing bevacizumab-induced intraocular inflammation

open access: yesIndian Journal of Ophthalmology, 2012
The outcome of four cases of sterile endophthalmitis that developed after intravitreal injections of bevacizumab has been reported here. All four eyes received 1.25 mg/0.05 ml intravitreal bevacizumab from 0.2-ml aliquots for different etiologies.
Subijay Sinha   +3 more
doaj   +1 more source

Intravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma

open access: yesAmerican Journal of Ophthalmology Case Reports, 2018
Purpose: To report a case of refractory glaucoma secondary to iris metastasis from breast cancer which was successfully treated with intravitreal bevacizumab.
Stephanie Vale   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy